Utah Kidney Diagnostics Company Renalytix AI Announces IPO
Exciting news comes our way this week with the announcement by BioUtah member, Renalytix AI (Renalytix), that the company is going public with a global offering of an aggregate of 11,000,000 new ordinary shares – U.S. IPO priced at $13.50 per ordinary share, and a concurrent private placement in Europe and other countries outside of […]